Antinausea medication linked to higher survival rates in women with triple negative breast cancer
By API User
A new study has found a commonly prescribed anti-nausea medication is associated with better prognosis for women with early-stage breast cancer, particularly triple negative breast cancer. The research team, co-led by Monash University and the Norwegian Institute of Public Health, evaluated Cancer Registry of Norway data of 13,811 women diagnosed with early-stage breast cancer … Continued